Rgx-314 Cohort 3 Data

2019 2:33
Synopsis
MD Magazine® sat down with Peter Campochiaro, MD, professor of ophthalmology, director of the retinal cell and molecular ...

You Might Also Like

What Are the Next Steps for RGX-314? 2:04
What Are The Next Steps For Rgx-314?
2019
Peter A. Campochiaro, MD: Phase 1/2a Data on RGX-314 Gene Therapy for Wet AMD 7:56
Peter A. Campochiaro, Md: Phase 1/2a Data On Rgx-314 Gene Th...
2025
The $20B Wet AMD Disruption Thesis: ABBV-RGX-314 and the Gene Therapy Bet 11:18
The $20b Wet Amd Disruption Thesis: Abbv-rgx-314 And The Gen...
2026
Jeffrey Heier: RGX-314 Gene Therapy Subretinal Delivery 1:50
Jeffrey Heier: Rgx-314 Gene Therapy Subretinal Delivery
2018
099 - Abbvie Announces MASSIVE Interest in REGENXBIO's RGX-314! Readout coming next week 45:49
099 - Abbvie Announces Massive Interest In Regenxbio's Rgx-3...
2022
Jo Brewer summarizes the allogeneic program data she presented at ASGCT 2019 1:56
Jo Brewer Summarizes The Allogeneic Program Data She Present...
2020
RET11 02 Section VIII Late Breaking Developments, Part I Results of Cohorts 1 5 for the RGX 314 5:30
Ret11 02 Section Viii Late Breaking Developments, Part I ...
2020
REGENXBIO 11:23
Regenxbio
2026
Can REGENXBIO Turn Retina into Anti-VEGF Factory? 4:53
Can Regenxbio Turn Retina Into Anti-vegf Factory?
2018
OIS Podcast Episode #343: The Game Changer 55:02
Ois Podcast Episode #343: The Game Changer
2023
041 - Is REGENXBIO a buy after Zolgensma approval? 30:30
041 - Is Regenxbio A Buy After Zolgensma Approval?
2020
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
Ssvid
MP4 & MP3 • HD Quality • Browser Extension Available
Download
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.